tm
Seeing Is Believing
tm
Seeing Is Believing
APGE is currently covered by 1 analysts with an average price target of $109.52. This is a potential upside of $41.74 (61.58%) from yesterday's end of day stock price of $67.78.
Apogee Therapeutics, Common Stock's activity chart (see below) currently has 19 price targets and 15 ratings on display. The stock rating distribution of APGE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 53.75% with an average time for these price targets to be met of 188.5 days.
Highest price target for APGE is $116, Lowest price target is $116, average price target is $116.
Most recent stock forecast was given by SEAMUS FERNANDEZ from GUGGENHEIM on 02-Jul-2025. First documented stock forecast 08-Aug-2023.
Currently out of the existing stock ratings of APGE, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Aug-2023
$116
$48.22 (71.14%)
7 months 13 days ago
(02-Jul-2025)
2/5 (40%)
$71.68 (161.73%)
102
Buy Since 08-Aug-2023
$90
$22.22 (32.78%)
$87
1 years 2 months 13 days ago
(02-Dec-2024)
1/4 (25%)
$43.86 (95.06%)
209
Buy Since 12-Jan-2024
$95
$27.22 (40.16%)
$46
1 years 11 months 10 days ago
(05-Mar-2024)
1/2 (50%)
$35.7 (60.20%)
53
Buy Since 08-Aug-2023
$75
$7.22 (10.65%)
$29
1 years 11 months 10 days ago
(05-Mar-2024)
2/2 (100%)
$15.7 (26.48%)
390
What is APGE (Apogee Therapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on APGE (Apogee Therapeutics, Common Stock) with a proven track record?
Which analyst has the current lower performing score on APGE (Apogee Therapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on APGE (Apogee Therapeutics, Common Stock)?
Which analyst is the currently most bullish on APGE (Apogee Therapeutics, Common Stock)?
Which analyst is the currently most reserved on APGE (Apogee Therapeutics, Common Stock)?
